CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clin Mol Hepatol. 2013;19(3):273-279. Published online 2013 September 30 DOI: https://doi.org/10.3350/cmh.2013.19.3.273

Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee

Clinical and Molecular Hepatology. 2013;19(3):273

Link1 Link2 Link3

Adefovir plus lamivudine combination therapy in lamivudine-resistant chronic hepatitis B

So Young Kwon

The Korean Journal of Hepatology. 2008;14(2):235

Link1 Link2 Link3

Failure of adefovir 20 mg to improve suboptimal response in lamivudine-resistant hepatitis B patients treated with adefovir 10 mg and lamivudine

M. Viganò, P. Lampertico, F. Facchetti, G. Lunghi, M. Colombo

Journal of Viral Hepatitis. 2008;15(12):922-924

Link1 Link2

Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern

J. Inoue, Y. Ueno, Y. Wakui, H. Niitsuma, K. Fukushima, Y. Yamagiwa, M. Shiina, Y. Kondo, E. Kakazu, K. Tamai, N. Obara, T. Iwasaki, T. Shimosegawa

Journal of Viral Hepatitis. 2011;18(3):206-215

Link1 Link2

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Jung Gil Park, Soo Young Park

Clinical and Molecular Hepatology. 2015;21(3):242

Link1 Link2 Link3

504 Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B

Journal of Hepatology. 2005;42:182

Link1 Link2

M1919 The Combination of Lamivudine and Adefovir Prevents Both Lamivudine and Adefovir Resistance in Patients with Chronic Hepatitis B

Christophe Hezode, Valerie Dhalluin-Venier, Stephane Chevaliez, Francoise Roudot-Thoraval, Ariane Mallat, Jean-Michel Pawlotsky

Gastroenterology. 2008;134(4):A-810

Link1 Link2

Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy

Samreen Ijaz, Catherine Arnold, Samir Dervisevic, Jana Mechurova, Nick Tatman, Richard S. Tedder, Nikolai V. Naoumov

Journal of Medical Virology. 2008;80(7):1160-1170

Link1 Link2

Antiviral Efficacy of Lamivudine/Adefovir Combination Therapy in Chronic Hepatitis B Patients with Resistance to Lamivudine and Adefovir Consecutively

Hyun Joo Suh, Moon Kyung Park, Hyang Ie Lee, Geum Yeon Gwak, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee

The Korean Journal of Gastroenterology. 2009;53(5):305

Link1 Link2 Link3

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up

Hiromi Yatsuji, Fumitaka Suzuki, Hitomi Sezaki, Norio Akuta, Yoshiyuki Suzuki, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Sachiyo Watahiki, Satomi Iwasaki, Mariko Kobayashi, Hiromitsu Kumada

Journal of Hepatology. 2008;48(6):923-931

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.